December 2024’s Stocks Estimated To Be Trading Below Their Fair Value

[Pelican Press 0]

This is the hidden content, please

• Sign In
• or
• Sign Up

December 2024’s Stocks Estimated To Be Trading Below Their Fair Value

As global markets continue to reach new heights, with major indices like the Dow Jones and S&P 500 hitting record intraday highs, investors are keenly observing the impact of geopolitical shifts and domestic policies on market sentiment. In this climate of robust gains yet underlying uncertainties, identifying stocks that may be trading below their fair value can offer potential opportunities for those looking to balance risk with potential reward.

Name

Current Price

Fair Value (Est)

Discount (Est)

NBT Bancorp (NasdaqGS:NBTB)

US$50.12

US$99.93

49.8%

DO & CO (WBAG:DOC)

€160.00

€317.78

49.6%

Stille (OM:STIL)

SEK220.00

SEK437.81

49.7%

Mobvista (SEHK:1860)

HK$8.00

HK$15.99

50%

Nidaros Sparebank (OB:NISB)

NOK100.00

NOK198.62

49.7%

Shanghai INT Medical Instruments (SEHK:1501)

HK$27.25

HK$54.31

49.8%

Charter Hall Group (ASX:CHC)

A$15.72

A$31.22

49.6%

EQL Pharma (OM:EQL)

SEK77.00

SEK153.58

49.9%

Hd Hyundai MipoLtd (KOSE:A010620)

₩125600.00

₩249514.81

49.7%

Hesai Group (NasdaqGS:HSAI)

US$8.18

US$16.30

49.8%

This is the hidden content, please

• Sign In
• or
• Sign Up

Let’s explore several standout options from the results in the screener.

Overview: Digital China Holdings Limited is an investment holding company that offers big data products and solutions to government and enterprise clients mainly in Mainland China, with a market capitalization of approximately HK$6.31 billion.

Operations: The company’s revenue is primarily derived from three segments: Big Data Products and Solutions (CN¥3.39 billion), Software and Operating Services (CN¥5.31 billion), and Traditional and Localization Services (CN¥10.03 billion).

Estimated Discount To Fair Value: 36.6%

Digital China Holdings is trading at HK$3.77, significantly below its estimated fair value of HK$5.94, indicating it is highly undervalued based on cash flows. While the company’s revenue growth of 9.8% annually outpaces the Hong Kong market average, its return on equity ******** low at 7.6%. Despite this, the firm is expected to become profitable within three years and demonstrates good relative value compared to peers and industry standards.

SEHK:861 Discounted Cash Flow as at Dec 2024

Overview: Beijing Huafeng Test & Control Technology Co., Ltd. operates in the field of test and control technology, with a market capitalization of approximately CN¥15.64 billion.

Story Continues

Operations: The company generates revenue primarily from the manufacturing of special equipment for semiconductor devices, amounting to CN¥793.33 million.

Estimated Discount To Fair Value: 16.6%

Beijing Huafeng Test & Control Technology Ltd. trades at CN¥115.62, below its estimated fair value of CN¥138.59, reflecting undervaluation based on cash flows. Recent earnings show a revenue increase to CNY 621.2 million and net income growth to CNY 213.09 million year-over-year, despite stable earnings per share. Forecasts predict substantial annual profit growth of 33.9% and revenue expansion of 25.9%, outpacing market averages, though return on equity ******** modest at 13%.

SHSE:688200 Discounted Cash Flow as at Dec 2024

Overview: Winner Medical Co., Ltd. focuses on the R&D, manufacture, and marketing of cotton-based medical dressings and disposables in China, with a market cap of CN¥20.36 billion.

Operations: Revenue Segments (in millions of CN¥):

Estimated Discount To Fair Value: 20.3%

Winner Medical is trading at CN¥34.97, significantly below its estimated fair value of CN¥43.89, indicating undervaluation based on cash flows. Despite a forecasted earnings growth of 71.91% per year and revenue expansion outpacing the ******** market, recent financials show a decline in net income to CN¥552.97 million from CN¥2,147.77 million last year. The dividend yield of 2.29% is not well supported by earnings or free cash flow, and return on equity is expected to remain low at 8.4%.

SZSE:300888 Discounted Cash Flow as at Dec 2024

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include SEHK:861 SHSE:688200 and SZSE:300888.

Have feedback on this article? Concerned about the content?

This is the hidden content, please

• Sign In
• or
• Sign Up

with us directly. Alternatively, email *****@*****.tld

This is the hidden content, please

• Sign In
• or
• Sign Up

#December #2024s #Stocks #Estimated #Trading #Fair

This is the hidden content, please

• Sign In
• or
• Sign Up

This is the hidden content, please

• Sign In
• or
• Sign Up